Perception of risk regarding the use of medications and other exposures during pregnancy
- 1.5k Downloads
Perception of risk may impact a woman’s decision to take a needed drug during pregnancy. There is a paucity of research on this topic in the literature.
(1) To evaluate the perception of risk of 17 commonly used drugs and other substances by pregnant women. (2) To investigate which sources of information regarding exposures during pregnancy were most commonly used by women.
A questionnaire was developed through the University of Oslo’s website for Internet surveys and posted on four Web pages used by pregnant women and mothers, from mid-September 2008 through October 2008. The inclusion criteria included women who were (1) pregnant or 2) a mother of a child less than 5 years old.
A total of 1,793 eligible women completed the questionnaire. Most women overestimated the teratogenic risk associated with all the drugs during pregnancy. Characteristics of the women that were associated with a high perception of risk were primiparity, higher age, higher education, and choosing not to use a drug during pregnancy. More than 80% of the women had used drugs during pregnancy, mostly paracetamol, penicillins and reflux medications. The physician, the product information leaflet and the pharmacist were the three most frequently used sources of information.
Women overestimate the risk of drug use and other exposures during pregnancy. Therefore, it is important for health care providers to use evidence-based information, to reduce unnecessary anxiety, and to ensure safe and appropriate treatment during pregnancy.
KeywordsRisk perception Pregnancy Medication
- 3.Einarson A (2007) The way women perceive teratogenic risk: how it can influence decision making during pregnancy regarding drug use or abortion of a wanted pregnancy. In: Koren G (ed) Medication safety in pregnancy and breastfeeding. McGraw-Hill, New York, pp 309–312Google Scholar
- 7.Organization of Teratology Information Specialists (OTIS) (2009) Home page. http://www.otispregnancy.org/hm/. Accessed 27 February 2009
- 8.European Network of Teratology Information Services (ENTIS) (2009) Home page. http://www.entis-org.com/. Accessed 27 February 2009
- 14.Schaefer C, Peters PWJ, Miller RK (eds) (2007) Drugs during pregnancy and lactation. Treatment options and risk assessment, 2nd ed. Academic Press, New YorkGoogle Scholar
- 16.University of Oslo, Norway (2009) Nettskjema. nettskjema.uio.no/index.html?lang=en. Accessed March 2009
- 17.John OP, Benet-Martinez V (2000) Measurement: reliability, construct validation, and scale construction. In: Reis HT, Judd CM (eds) Handbook of research methods in social and personality psychology. Cambridge University Press, New York, pp 339–369Google Scholar
- 18.Norwegian Institute of Public Health (2006) Medical birth registry of Norway annual report 2003–2004. NIPS, OsloGoogle Scholar
- 19.Statistics Norway (2008) Population. Table 03031: population by sex, age and marital status 2008. http://www.ssb.no/english/. Accessed 1 December 2009
- 20.Statistics Norway (2007) Education level in the population. Table 3: population 16 years and over by, by level of education, gender and age 2007. http://www.ssb.no/english/. Accessed 1 December 2009
- 23.Holst L, Wright D, Nordeng H, Haavik S (2009) Use of herbal preparations during pregnancy. focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich UK. Complement Ther Clin Pract (in press)Google Scholar
- 27.Statistics Norway (2008) Use of ICT in households, 2nd quarter 2008. http://www.ssb.no/english/subjects/10/03/ikthus_en/. Accessed 1 December 2008